Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Application of diagnostic criteria for non-tuberculous mycobacterial disease to a case series of mycobacterial-positive isolates.

Ghio AJ, Smith GS, DeFlorio-Barker S, Messier KP, Hudgens E, Murphy MS, Maillard JM, Stout JE, Hilborn ED.

J Clin Tuberc Other Mycobact Dis. 2019 Nov 16;17:100133. doi: 10.1016/j.jctube.2019.100133. eCollection 2019 Dec.

2.

Water Quality as a Predictor of Legionella Positivity of Building Water Systems.

Pierre D, Baron JL, Ma X, Sidari FP 3rd, Wagener MM, Stout JE.

Pathogens. 2019 Dec 13;8(4). pii: E295. doi: 10.3390/pathogens8040295.

3.

Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.

Stout JE, Turner NA, Belknap RW, Horsburgh CR, Sterling TR, Phillips PPJ.

Am J Respir Crit Care Med. 2019 Nov 11. doi: 10.1164/rccm.201908-1606OC. [Epub ahead of print]

PMID:
31711306
4.

Point-of-use filters for prevention of health care-acquired Legionnaires' disease: Field evaluation of a new filter product and literature review.

Parkinson J, Baron JL, Hall B, Bos H, Racine P, Wagener MM, Stout JE.

Am J Infect Control. 2020 Feb;48(2):132-138. doi: 10.1016/j.ajic.2019.09.006. Epub 2019 Oct 25.

PMID:
31668765
5.

Papulonecrotic tuberculid and Poncet disease: A case of multisystem delayed-type hypersensitivity in a patient with Mycobacterium tuberculosis infection.

Whitley MJ, Stout JE, Kapila A, Selim MA, Mansoori P, Marano AL.

JAAD Case Rep. 2019 Aug 29;5(9):794-797. doi: 10.1016/j.jdcr.2019.07.002. eCollection 2019 Sep. No abstract available.

6.

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.

Stout JE, Sterling TR, Horsburgh CR Jr.

N Engl J Med. 2019 Sep 12;381(11):e23. doi: 10.1056/NEJMc1908492. No abstract available.

PMID:
31509689
7.

Simulation of Legionnaires' disease prospective spatiotemporal cluster detection, Allegheny County, Pennsylvania, USA.

Orkis LT, Peterson ER, Brooks MM, Mertz KJ, Harrison LH, Stout JE, Greene SK.

Epidemiol Infect. 2018 Oct 18:1-9. doi: 10.1017/S0950268818002789. [Epub ahead of print]

8.

Impact of radiology reports on timely tuberculosis diagnosis.

Dicks KV, Holland DP, Allen MG, Fortenberry ER, Luffman J, Zeringue E, Wheeler J, Stout JE.

Postgrad Med J. 2018 Sep;94(1115):495-498. doi: 10.1136/postgradmedj-2018-135984. Epub 2018 Sep 19.

PMID:
30232151
9.

Molecular Diagnostics for Mycobacterium tuberculosis Infection.

Dicks KV, Stout JE.

Annu Rev Med. 2019 Jan 27;70:77-90. doi: 10.1146/annurev-med-040717-051502. Epub 2018 Aug 20. Review.

PMID:
30125128
10.

Evaluating latent tuberculosis infection diagnostics using latent class analysis.

Stout JE, Wu Y, Ho CS, Pettit AC, Feng PJ, Katz DJ, Ghosh S, Venkatappa T, Luo R; Tuberculosis Epidemiologic Studies Consortium.

Thorax. 2018 Nov;73(11):1062-1070. doi: 10.1136/thoraxjnl-2018-211715. Epub 2018 Jul 7.

11.

Health Care Utilization Behaviors Predict Disengagement From HIV Care: A Latent Class Analysis.

Okeke NL, Clement ME, McKellar MS, Stout JE.

Open Forum Infect Dis. 2018 Apr 24;5(5):ofy088. doi: 10.1093/ofid/ofy088. eCollection 2018 May.

12.

Environmental sources of community-acquired legionnaires' disease: A review.

Orkis LT, Harrison LH, Mertz KJ, Brooks MM, Bibby KJ, Stout JE.

Int J Hyg Environ Health. 2018 Jun;221(5):764-774. doi: 10.1016/j.ijheh.2018.04.013. Epub 2018 Apr 30. Review.

PMID:
29729999
13.

Nocardia infections in the transplanted host.

Hemmersbach-Miller M, Stout JE, Woodworth MH, Cox GM, Saullo JL.

Transpl Infect Dis. 2018 Aug;20(4):e12902. doi: 10.1111/tid.12902. Epub 2018 May 7.

14.

Paradox of serial interferon-gamma release assays: variability width more important than specificity size.

Stout JE, Belknap R, Wu YJ, Ho CS.

Int J Tuberc Lung Dis. 2018 May 1;22(5):518-523. doi: 10.5588/ijtld.17.0650.

PMID:
29663956
15.

Corticosteroids for tuberculous pericarditis: can we learn from variability?

Johnson DF, Stout JE.

Int J Tuberc Lung Dis. 2018 May 1;22(5):475. doi: 10.5588/ijtld.18.0134. No abstract available.

PMID:
29663948
16.

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.

van Ingen J, Aksamit T, Andrejak C, Böttger EC, Cambau E, Daley CL, Griffith DE, Guglielmetti L, Holland SM, Huitt GA, Koh WJ, Lange C, Leitman P, Marras TK, Morimoto K, Olivier KN, Santin M, Stout JE, Thomson R, Tortoli E, Wallace RJ Jr, Winthrop KL, Wagner D; for NTM-NET.

Eur Respir J. 2018 Mar 22;51(3). pii: 1800170. doi: 10.1183/13993003.00170-2018. Print 2018 Mar. No abstract available.

17.

Annotated Genome Sequences of 16 Lineage 4 Mycobacterium tuberculosis Strains from Guatemala.

Saelens JW, Lau-Bonilla D, Moller A, Xet-Mull AM, Medina N, Guzmán B, Calderón M, Herrera R, Stout JE, Arathoon E, Samayoa B, Tobin DM.

Genome Announc. 2018 Feb 15;6(7). pii: e00024-18. doi: 10.1128/genomeA.00024-18.

18.

Diagnostic testing for Legionnaires' disease.

Pierre DM, Baron J, Yu VL, Stout JE.

Ann Clin Microbiol Antimicrob. 2017 Aug 29;16(1):59. doi: 10.1186/s12941-017-0229-6. Review.

19.

Suboptimal HIV Testing Among Patients Admitted With Pneumonia: A Missed Opportunity.

Clifton DC, Clement ME, Holland TL, Cox GM, Dicks KV, Stout JE.

AIDS Educ Prev. 2017 Aug;29(4):377-388. doi: 10.1521/aeap.2017.29.4.377.

20.
21.

A Breath of Fresh Air for Patients with Pulmonary Nontuberculous Mycobacterial Infection.

Stout JE, Dicks KV.

Am J Respir Crit Care Med. 2017 Mar 15;195(6):716-717. doi: 10.1164/rccm.201610-2073ED. No abstract available.

PMID:
28294651
22.

Increasing Nocardia Incidence Associated with Bronchiectasis at a Tertiary Care Center.

Woodworth MH, Saullo JL, Lantos PM, Cox GM, Stout JE.

Ann Am Thorac Soc. 2017 Mar;14(3):347-354. doi: 10.1513/AnnalsATS.201611-907OC.

PMID:
28231023
23.

Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation.

Baker AW, Lewis SS, Alexander BD, Chen LF, Wallace RJ Jr, Brown-Elliott BA, Isaacs PJ, Pickett LC, Patel CB, Smith PK, Reynolds JM, Engel J, Wolfe CR, Milano CA, Schroder JN, Davis RD, Hartwig MG, Stout JE, Strittholt N, Maziarz EK, Saullo JH, Hazen KC, Walczak RJ Jr, Vasireddy R, Vasireddy S, McKnight CM, Anderson DJ, Sexton DJ.

Clin Infect Dis. 2017 Apr 1;64(7):902-911. doi: 10.1093/cid/ciw877.

24.

Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and Promotes Infection.

Cronan MR, Beerman RW, Rosenberg AF, Saelens JW, Johnson MG, Oehlers SH, Sisk DM, Jurcic Smith KL, Medvitz NA, Miller SE, Trinh LA, Fraser SE, Madden JF, Turner J, Stout JE, Lee S, Tobin DM.

Immunity. 2016 Oct 18;45(4):861-876. doi: 10.1016/j.immuni.2016.09.014.

25.

Infection-Induced Vascular Permeability Aids Mycobacterial Growth.

Oehlers SH, Cronan MR, Beerman RW, Johnson MG, Huang J, Kontos CD, Stout JE, Tobin DM.

J Infect Dis. 2017 Mar 1;215(5):813-817. doi: 10.1093/infdis/jiw355.

26.

Calculating the economic benefits of what didn't happen.

Stout JE, Dicks KV.

Int J Tuberc Lung Dis. 2016 Jul;20(7):854. doi: 10.5588/ijtld.16.0345. No abstract available.

PMID:
27287632
27.

Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.

Holland DP, Hamilton CD, Stout JE.

Int J Tuberc Lung Dis. 2016 Jun;20(6):827-31. doi: 10.5588/ijtld.15.0006.

PMID:
27155188
28.

Getting to a Man's Heart through His Colon.

Samsky MD, DeVore AD, Durkin M, Stout JE, Velazquez EJ, Milano CA.

Tex Heart Inst J. 2016 Apr 1;43(2):168-70. doi: 10.14503/THIJ-14-4946. eCollection 2016 Apr.

29.

Medium matters: modeling the impact of solid medium performance on tuberculosis trial sample size requirements.

Johnson MG, Stout JE, Benator DA, Whitworth WC, Holland DP.

Int J Tuberc Lung Dis. 2016 May;20(5):600-4. doi: 10.5588/ijtld.15.0570.

30.

A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP).

Phillips PP, Dooley KE, Gillespie SH, Heinrich N, Stout JE, Nahid P, Diacon AH, Aarnoutse RE, Kibiki GS, Boeree MJ, Hoelscher M.

BMC Med. 2016 Mar 23;14:51. doi: 10.1186/s12916-016-0597-3.

31.

Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010.

Smith GS, Ghio AJ, Stout JE, Messier KP, Hudgens EE, Murphy MS, Pfaller SL, Maillard JM, Hilborn ED.

J Infect. 2016 Jun;72(6):678-686. doi: 10.1016/j.jinf.2016.03.008. Epub 2016 Mar 18.

PMID:
26997636
32.

Update on pulmonary disease due to non-tuberculous mycobacteria.

Stout JE, Koh WJ, Yew WW.

Int J Infect Dis. 2016 Apr;45:123-34. doi: 10.1016/j.ijid.2016.03.006. Epub 2016 Mar 11. Review.

33.

Association Between Staff Experience and Effective Tuberculosis Contact Tracing in North Carolina, 2008-2009.

Bryant KE, Allen MG, Fortenberry ER, Luffman J, Zeringue E, Stout JE.

N C Med J. 2016 Jan-Feb;77(1):37-44. doi: 10.18043/ncm.77.1.37.

34.

Should all patients undergoing treatment with biologic agents be screened annually for latent tuberculosis infection with an interferon gamma release assay?

Johnson MG, Bialas RW, Hall RP, Stout JE.

J Dermatolog Treat. 2016 Aug;27(4):378-80. doi: 10.3109/09546634.2015.1115815. Epub 2015 Dec 10.

35.

The cost of 'free' tuberculosis care.

Stout JE.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1413. doi: 10.5588/ijtld.15.0818. No abstract available.

PMID:
26614179
36.

Whole genome sequencing identifies circulating Beijing-lineage Mycobacterium tuberculosis strains in Guatemala and an associated urban outbreak.

Saelens JW, Lau-Bonilla D, Moller A, Medina N, Guzmán B, Calderón M, Herrera R, Sisk DM, Xet-Mull AM, Stout JE, Arathoon E, Samayoa B, Tobin DM.

Tuberculosis (Edinb). 2015 Dec;95(6):810-816. doi: 10.1016/j.tube.2015.09.001. Epub 2015 Sep 28.

37.

Mental Health and Substance Use Among Patients in a North Carolina HIV Clinic.

Skalski LM, Watt MH, MacFarlane JC, Proeschold-Bell RJ, Stout JE, Sikkema KJ.

N C Med J. 2015 Jul-Aug;76(3):148-55. doi: 10.18043/ncm.76.3.148.

38.

Lack of correlation between Legionella colonization and microbial population quantification using heterotrophic plate count and adenosine triphosphate bioluminescence measurement.

Duda S, Baron JL, Wagener MM, Vidic RD, Stout JE.

Environ Monit Assess. 2015 Jul;187(7):393. doi: 10.1007/s10661-015-4612-5. Epub 2015 Jun 3.

PMID:
26038316
39.

Twenty-eight cases of Mycobacterium marinum infection: retrospective case series and literature review.

Johnson MG, Stout JE.

Infection. 2015 Dec;43(6):655-62. doi: 10.1007/s15010-015-0776-8. Epub 2015 Apr 14. Review.

40.

Effect of monochloramine treatment on the microbial ecology of Legionella and associated bacterial populations in a hospital hot water system.

Baron JL, Harris JK, Holinger EP, Duda S, Stevens MJ, Robertson CE, Ross KA, Pace NR, Stout JE.

Syst Appl Microbiol. 2015 May;38(3):198-205. doi: 10.1016/j.syapm.2015.02.006. Epub 2015 Mar 20.

PMID:
25840824
41.

Clinical utility of indium 111-labeled white blood cell scintigraphy for evaluation of suspected infection.

Lewis SS, Cox GM, Stout JE.

Open Forum Infect Dis. 2014 Sep 17;1(2):ofu089. doi: 10.1093/ofid/ofu089. eCollection 2014 Sep.

42.

The complexities of Xpert® MTB/RIF interpretation.

Lippincott CK, Miller MB, Van Rie A, Weber DJ, Sena AC, Stout JE.

Int J Tuberc Lung Dis. 2015 Mar;19(3):273-5. doi: 10.5588/ijtld.14.0432.

PMID:
25686132
43.

Fungal diversity and presence of potentially pathogenic fungi in a hospital hot water system treated with on-site monochloramine.

Ma X, Baron JL, Vikram A, Stout JE, Bibby K.

Water Res. 2015 Mar 15;71:197-206. doi: 10.1016/j.watres.2014.12.052. Epub 2015 Jan 8.

PMID:
25618520
44.

Treating multidrug-resistant tuberculosis in community settings: a wise investment.

Andrews JR, Stout JE.

Int J Tuberc Lung Dis. 2015 Feb;19(2):127. doi: 10.5588/ijtld.14.0761. No abstract available.

PMID:
25574906
45.

Isoniazid preventive therapy in medium-incidence settings: the price is right.

Stout JE, Andrews JR.

Int J Tuberc Lung Dis. 2014 Dec;18(12):1388. doi: 10.5588/ijtld.14.0760. No abstract available.

PMID:
25517800
46.

Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

Dorman SE, Savic RM, Goldberg S, Stout JE, Schluger N, Muzanyi G, Johnson JL, Nahid P, Hecker EJ, Heilig CM, Bozeman L, Feng PJ, Moro RN, MacKenzie W, Dooley KE, Nuermberger EL, Vernon A, Weiner M; Tuberculosis Trials Consortium.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):333-43. doi: 10.1164/rccm.201410-1843OC. Erratum in: Am J Respir Crit Care Med. 2015 May 15;191(10):1210.

47.

Editorial commentary: risk assessment and prediction for health care-associated Legionnaires' disease: percent distal site positivity as a cut-point.

Pierre D, Stout JE, Yu VL.

Am J Infect Control. 2014 Nov;42(11):1248-50. doi: 10.1016/j.ajic.2014.06.032. Epub 2014 Oct 30. No abstract available.

PMID:
25444274
48.

Evaluation of a new monochloramine generation system for controlling Legionella in building hot water systems.

Duda S, Kandiah S, Stout JE, Baron JL, Yassin M, Fabrizio M, Ferrelli J, Hariri R, Wagener MM, Goepfert J, Bond J, Hannigan J, Rogers D.

Infect Control Hosp Epidemiol. 2014 Nov;35(11):1356-63. doi: 10.1086/678418. Epub 2014 Sep 19.

PMID:
25333430
49.

Field evaluation of a new point-of-use faucet filter for preventing exposure to Legionella and other waterborne pathogens in health care facilities.

Baron JL, Peters T, Shafer R, MacMurray B, Stout JE.

Am J Infect Control. 2014 Nov;42(11):1193-6. doi: 10.1016/j.ajic.2014.08.002. Epub 2014 Sep 16.

PMID:
25234046
50.

Advances in the management of pulmonary disease due to Mycobacterium abscessus complex.

Koh WJ, Stout JE, Yew WW.

Int J Tuberc Lung Dis. 2014 Oct;18(10):1141-8. doi: 10.5588/ijtld.14.0134. Review.

PMID:
25216826

Supplemental Content

Loading ...
Support Center